Why the study?
Does combined antisense cdc2 kinase and PCNA ODN delivery prevent neointima formation in a rat carotid balloon-injury model?
Population
Rat carotid balloon-injury model and in vitro vascular smooth muscle cells
Comparison
Single intraluminal delivery of combined… vs Sense controls, antisense cdc2 kinase ODNs…
Design
Preclinical
Follow-up
up to 8 weeks
Authors
Loading...
No clinical translation yet; leaves open whether antisense ODN efficacy extends from rat models to human restenosis prevention.
Does combined antisense cdc2 kinase and PCNA ODN delivery prevent neointima formation in a rat carotid balloon-injury model?
Combined antisense oligonucleotide therapy targeting cdc2 kinase and PCNA effectively prevents neointimal hyperplasia in a rat model of balloon angioplasty injury.
Morishita et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: